interim analysis

Hyderabad: For those who are still a tad hesitant in taking the Covaxin jab, there’s reassuring news. The phase 3 interim analysis of the Bharat Biotech-manufactured coronavirus vaccine was announced on Wednesday. And it points to 78%…